查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1968674

生物製药生产设备及耗材市场分析及预测（至2035年）：类型、产品、服务、技术、组件、应用、材质类型、製程、最终用户及功能

Biopharmaceutical Processing Equipment And Consumables Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Material Type, Process, End User, Functionality
出版日期: | 出版商: Global Insight Services | 英文 474 Pages | 商品交期: 3-5个工作天内

价格
简介目录

生物製药生产设备及耗材市场预计将从2024年的438亿美元成长至2034年的1,076亿美元，复合年增长率约为9.4%。该市场涵盖药物研发和生产所需的关键设备和材料，例如生物反应器、过滤系统和层析法设备。该产业为生物製药、疫苗和生物相似药的生产提供支持。对个人化医疗和生物製药日益增长的需求正在推动市场成长，而一次性技术和流程自动化的进步则提高了效率和扩充性。

生物製药生产设备及耗材市场正经历强劲成长，主要得益于生物製药和生物相似药生产技术的进步。设备领域在该市场中占据主导地位，其中生物反应器和过滤系统是高效生物製程的关键设备。层析法系统在提升纯化製程方面也扮演重要角色。耗材领域紧随其后，尤其是过滤耗材和层析法树脂，它们在确保产品纯度和品质方面发挥着至关重要的作用。一次性技术因其成本效益和降低污染风险而日益普及，对成熟和新兴的生物製药企业都极具吸引力。下游设备和耗材的需求不断增长，反映出该产业对优化纯化和分离製程的重视。自动化和流程分析领域的创新透过提高营运效率和产品一致性，进一步推动了市场成长。对个人化医疗以及细胞和基因疗法的日益关注预计将推动未来的市场扩张，为这个充满活力的市场中的相关人员带来盈利的机会。

市场区隔
类型 一次性使用，可重复使用
产品 过滤系统、层析法系统、生物反应器、混合器、离心机、袋装和容器、管路、连接器、阀门
服务 安装、维护、验证、资格确认、培训
科技 上游工程、下游製程、细胞培养、发酵、纯化
成分 感测器、控制器、马达、泵浦
应用 单株抗体、疫苗、重组蛋白、细胞疗法、基因疗法
材质 不锈钢、塑胶、玻璃
过程 批量处理，连续处理
最终用户 生物製药公司、契约製造组织、学术研究机构
功能 自动化、手动

市场概况：

生物製药加工设备及耗材市场的特征是市占率分布动态变化、定价策略灵活、创新产品层出不穷。主要企业不断利用最尖端科技拓展产品系列，以满足生物製药产业不断变化的需求。这种策略扩张的驱动力在于提高药物研发和生产流程的效率和生产力。一次性系统因其成本效益和操作柔软性而备受青睐，市场需求激增。北美和欧洲引领市场，而亚太地区的新兴经济体正凭藉着不断增长的投资迅速追赶。竞争基准分析显示，市场结构高度分散，多家主要企业竞相争取主导。监管影响，尤其是在北美和欧洲，透过制定严格的品质和安全标准，在塑造市场动态发挥关键作用。企业越来越重视合规性，以获得竞争优势。技术进步使自动化数位化成为企业营运的核心，这也对市场产生影响。这些因素，加上研发投入的不断增加，共同推动了市场成长。儘管营运成本高、监管环境复杂等挑战依然存在，但在生物製程技术创新的支持下，市场前景依然乐观。

主要趋势和驱动因素：

生物製药生产设备和耗材市场正经历强劲成长，这主要得益于技术创新和对生物製药日益增长的需求。关键趋势包括一次性技术的应用，这些技术在生产过程中具有成本效益和柔软性。由于它们能够降低污染风险并提高生产效率，因此变得至关重要。慢性病的增加是推动市场成长的关键因素，这需要先进的生物製药解决方案。这种需求促使企业不断创新产品并拓展产品线。此外，监管部门对生物製药和生物相似药的支持也促进了市场扩张，简化的核准流程缩短了产品上市时间。生物製程的客製化和扩充性正成为关键趋势。企业正在投资建造可根据特定生产需求量身定制的模组化设施，从而确保适应性和效率。此外，自动化和数据分析等数位技术的整合正在革新製程优化，并实现即时监控。这些进步为市场参与者创造了盈利机会，使其能够提高产能并满足不断增长的全球需求。

限制与挑战：

生物製药生产设备和耗材市场面临许多重大限制和挑战。其中一个主要挑战是先进设备的高成本，这可能会阻碍中小企业进入市场。这种财务壁垒限制了创新和竞争。此外，严格的监管要求导致产品核可延迟和营运成本增加。遵守这些法规需要投入大量的时间和资源。另外，生物製药製程的复杂性需要熟练的专业人员，但合格人员却短缺。这种技能缺口会阻碍高效率营运和创新。供应链中断，尤其是受全球事件影响的供应链中断，也影响了原料和设备的及时采购。最后，技术的快速发展可能导致现有设备过时，需要不断投资进行设备升级，这可能会对企业造成沉重的财务负担。这些因素共同限制了市场成长，并构成了进入障碍。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 一次性
    • 可重复使用类型
  • 市场规模及预测：依产品划分
    • 过滤系统
    • 层析法系统
    • 生物反应器
    • 混合器
    • 离心机
    • 袋子和容器
    • 管子
    • 连接器
    • 阀门
  • 市场规模及预测：依服务划分
    • 安装
    • 维护管理
    • 验证
    • 资格
    • 训练
  • 市场规模及预测：依技术划分
    • 上游工程
    • 下游工艺
    • 细胞培养
    • 发酵
    • 纯化
  • 市场规模及预测：依组件划分
    • 感应器
    • 控制器
    • 引擎
    • 泵浦
  • 市场规模及预测：依应用领域划分
    • 单株抗体
    • 疫苗
    • 重组蛋白
    • 细胞疗法
    • 基因治疗
  • 市场规模及预测：依材料类型划分
    • 不銹钢
    • 塑胶
    • 玻璃
  • 市场规模及预测：依製程划分
    • 批量处理
    • 连续加工
  • 市场规模及预测：依最终用户划分
    • 生物製药公司
    • 契约製造组织
    • 学术研究机构
  • 市场规模及预测：依功能划分
    • 自动化
    • 手动的

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Sartorius Stedim Biotech
  • Eppendorf AG
  • GEA Group
  • Pall Corporation
  • Merck Millipore
  • Thermo Fisher Scientific
  • Watson-Marlow Fluid Technology Group
  • Repligen Corporation
  • Avantor Inc
  • Corning Incorporated
  • Sani-Tech West
  • Sartorius AG
  • 3M Company
  • Danaher Corporation
  • Applikon Biotechnology
  • Meissner Filtration Products
  • Parker Hannifin Corporation
  • Saint-Gobain Life Sciences
  • Cole-Parmer
  • Getinge AB

第九章：关于我们

简介目录
Product Code: GIS33054

Biopharmaceutical Processing Equipment And Consumables Market is anticipated to expand from $43.8 billion in 2024 to $107.6 billion by 2034, growing at a CAGR of approximately 9.4%. The Biopharmaceutical Processing Equipment and Consumables Market encompasses tools and materials essential for drug development and production, including bioreactors, filtration systems, and chromatography tools. This sector supports the manufacture of biologics, vaccines, and biosimilars. Increasing demand for personalized medicine and biologics is propelling growth, with advancements in single-use technologies and process automation enhancing efficiency and scalability.

The Biopharmaceutical Processing Equipment and Consumables Market is experiencing robust growth, fueled by advancements in biologics and biosimilars production. Within this market, the equipment segment is leading, with bioreactors and filtration systems being pivotal for efficient bioprocessing. Chromatography systems also play a significant role, enhancing purification processes. The consumables segment, particularly filtration consumables and chromatography resins, follows closely, driven by their critical function in ensuring product purity and quality. Single-use technologies are gaining momentum due to their cost-effectiveness and reduced contamination risk, appealing to both established and emerging biopharmaceutical manufacturers. Downstream processing equipment and consumables are witnessing increased demand, reflecting the industry's focus on optimizing purification and separation processes. Innovations in automation and process analytics are further propelling market growth, as they enhance operational efficiency and product consistency. The emphasis on personalized medicine and cell and gene therapies is expected to drive future expansion, offering lucrative opportunities for stakeholders in this dynamic market.

Market Segmentation
TypeSingle-Use, Reusable
ProductFiltration Systems, Chromatography Systems, Bioreactors, Mixers, Centrifuges, Bags and Containers, Tubes, Connectors, Valves
ServicesInstallation, Maintenance, Validation, Qualification, Training
TechnologyUpstream Processing, Downstream Processing, Cell Culture, Fermentation, Purification
ComponentSensors, Controllers, Motors, Pumps
ApplicationMonoclonal Antibodies, Vaccines, Recombinant Proteins, Cell Therapy, Gene Therapy
Material TypeStainless Steel, Plastic, Glass
ProcessBatch Processing, Continuous Processing
End UserBiopharmaceutical Companies, Contract Manufacturing Organizations, Academic and Research Institutes
FunctionalityAutomated, Manual

Market Snapshot:

The biopharmaceutical processing equipment and consumables market is characterized by a dynamic landscape of market share distribution, strategic pricing, and innovative product launches. Leading companies are continuously expanding their portfolios with cutting-edge technologies to cater to the evolving demands of the biopharmaceutical sector. This strategic expansion is driven by the need for enhanced efficiency and productivity in drug development and manufacturing processes. The market is witnessing a surge in demand for single-use systems, driven by their cost-effectiveness and operational flexibility. Geographically, North America and Europe are at the forefront of this market, while emerging economies in Asia-Pacific are rapidly catching up due to increased investments. Competitive benchmarking reveals a highly fragmented market with several key players vying for dominance. Regulatory influences, particularly in North America and Europe, play a pivotal role in shaping market dynamics, setting stringent standards for quality and safety. Companies are increasingly focusing on compliance to gain a competitive edge. The market is also influenced by technological advancements, with automation and digitalization becoming central to operations. These factors, coupled with increasing R&D investments, are driving growth. Challenges such as high operational costs and complex regulatory landscapes persist, yet the market's future outlook remains optimistic, bolstered by innovations in bioprocessing technologies.

Geographical Overview:

The biopharmaceutical processing equipment and consumables market is witnessing robust expansion across diverse regions. North America leads, propelled by its advanced healthcare infrastructure and substantial investments in biopharmaceutical research and development. The region's focus on innovation and technological advancements enhances its market dominance. Europe follows, with strong regulatory frameworks and a thriving pharmaceutical industry driving growth. The region's emphasis on quality and compliance bolsters its market position. In Asia Pacific, the market is burgeoning, supported by rapid industrialization and increasing healthcare demands. Countries like China and India are emerging as major growth pockets, owing to their large patient populations and expanding pharmaceutical sectors. Latin America and the Middle East & Africa are also gaining traction. In Latin America, government initiatives to bolster healthcare infrastructure are contributing to market growth. Meanwhile, the Middle East & Africa are recognizing the potential of biopharmaceutical processing equipment in advancing healthcare outcomes and fostering economic development.

Key Trends and Drivers:

The biopharmaceutical processing equipment and consumables market is experiencing robust growth fueled by technological advancements and increasing demand for biologics. Key trends include the adoption of single-use technologies, which offer cost-effectiveness and flexibility in manufacturing processes. These technologies are becoming vital as they reduce contamination risks and enhance production efficiency. The growing prevalence of chronic diseases is a significant driver, necessitating advanced biopharmaceutical solutions. This demand is pushing companies to innovate and expand their product pipelines. Furthermore, regulatory support for biologics and biosimilars is encouraging market expansion, as streamlined approval processes facilitate quicker time-to-market. Customization and scalability in bioprocessing are emerging as crucial trends. Companies are investing in modular equipment that can be tailored to specific production needs, ensuring adaptability and efficiency. Additionally, the integration of digital technologies like automation and data analytics is revolutionizing process optimization, providing real-time monitoring and control. These advancements are creating lucrative opportunities for market players to enhance production capabilities and meet the rising global demand.

Restraints and Challenges:

The biopharmaceutical processing equipment and consumables market faces several significant restraints and challenges. One primary challenge is the high cost of advanced equipment, which can deter small and medium-sized enterprises from entering the market. This financial barrier limits innovation and competition. Additionally, stringent regulatory requirements can delay product approvals and increase operational costs. Compliance with these regulations demands significant investment in time and resources. Furthermore, the complexity of biopharmaceutical processes necessitates skilled personnel, yet there is a shortage of qualified professionals. This skills gap can hinder efficient operations and innovation. Supply chain disruptions, exacerbated by global events, pose another challenge, affecting the timely availability of raw materials and equipment. Lastly, the rapid pace of technological advancements can render existing equipment obsolete, necessitating continuous investment in upgrades, which can be financially burdensome for companies. These factors collectively constrain market growth and accessibility.

Key Players:

Sartorius Stedim Biotech, Eppendorf AG, GEA Group, Pall Corporation, Merck Millipore, Thermo Fisher Scientific, Watson-Marlow Fluid Technology Group, Repligen Corporation, Avantor Inc, Corning Incorporated, Sani-Tech West, Sartorius AG, 3M Company, Danaher Corporation, Applikon Biotechnology, Meissner Filtration Products, Parker Hannifin Corporation, Saint-Gobain Life Sciences, Cole-Parmer, Getinge AB

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Material Type
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by End User
  • 2.10 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Single-Use
    • 4.1.2 Reusable
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Filtration Systems
    • 4.2.2 Chromatography Systems
    • 4.2.3 Bioreactors
    • 4.2.4 Mixers
    • 4.2.5 Centrifuges
    • 4.2.6 Bags and Containers
    • 4.2.7 Tubes
    • 4.2.8 Connectors
    • 4.2.9 Valves
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Installation
    • 4.3.2 Maintenance
    • 4.3.3 Validation
    • 4.3.4 Qualification
    • 4.3.5 Training
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Upstream Processing
    • 4.4.2 Downstream Processing
    • 4.4.3 Cell Culture
    • 4.4.4 Fermentation
    • 4.4.5 Purification
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Sensors
    • 4.5.2 Controllers
    • 4.5.3 Motors
    • 4.5.4 Pumps
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Monoclonal Antibodies
    • 4.6.2 Vaccines
    • 4.6.3 Recombinant Proteins
    • 4.6.4 Cell Therapy
    • 4.6.5 Gene Therapy
  • 4.7 Market Size & Forecast by Material Type (2020-2035)
    • 4.7.1 Stainless Steel
    • 4.7.2 Plastic
    • 4.7.3 Glass
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Batch Processing
    • 4.8.2 Continuous Processing
  • 4.9 Market Size & Forecast by End User (2020-2035)
    • 4.9.1 Biopharmaceutical Companies
    • 4.9.2 Contract Manufacturing Organizations
    • 4.9.3 Academic and Research Institutes
  • 4.10 Market Size & Forecast by Functionality (2020-2035)
    • 4.10.1 Automated
    • 4.10.2 Manual

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Material Type
      • 5.2.1.8 Process
      • 5.2.1.9 End User
      • 5.2.1.10 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Material Type
      • 5.2.2.8 Process
      • 5.2.2.9 End User
      • 5.2.2.10 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Material Type
      • 5.2.3.8 Process
      • 5.2.3.9 End User
      • 5.2.3.10 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Material Type
      • 5.3.1.8 Process
      • 5.3.1.9 End User
      • 5.3.1.10 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Material Type
      • 5.3.2.8 Process
      • 5.3.2.9 End User
      • 5.3.2.10 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Material Type
      • 5.3.3.8 Process
      • 5.3.3.9 End User
      • 5.3.3.10 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Material Type
      • 5.4.1.8 Process
      • 5.4.1.9 End User
      • 5.4.1.10 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Material Type
      • 5.4.2.8 Process
      • 5.4.2.9 End User
      • 5.4.2.10 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Material Type
      • 5.4.3.8 Process
      • 5.4.3.9 End User
      • 5.4.3.10 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Material Type
      • 5.4.4.8 Process
      • 5.4.4.9 End User
      • 5.4.4.10 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Material Type
      • 5.4.5.8 Process
      • 5.4.5.9 End User
      • 5.4.5.10 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Material Type
      • 5.4.6.8 Process
      • 5.4.6.9 End User
      • 5.4.6.10 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Material Type
      • 5.4.7.8 Process
      • 5.4.7.9 End User
      • 5.4.7.10 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Material Type
      • 5.5.1.8 Process
      • 5.5.1.9 End User
      • 5.5.1.10 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Material Type
      • 5.5.2.8 Process
      • 5.5.2.9 End User
      • 5.5.2.10 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Material Type
      • 5.5.3.8 Process
      • 5.5.3.9 End User
      • 5.5.3.10 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Material Type
      • 5.5.4.8 Process
      • 5.5.4.9 End User
      • 5.5.4.10 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Material Type
      • 5.5.5.8 Process
      • 5.5.5.9 End User
      • 5.5.5.10 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Material Type
      • 5.5.6.8 Process
      • 5.5.6.9 End User
      • 5.5.6.10 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Material Type
      • 5.6.1.8 Process
      • 5.6.1.9 End User
      • 5.6.1.10 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Material Type
      • 5.6.2.8 Process
      • 5.6.2.9 End User
      • 5.6.2.10 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Material Type
      • 5.6.3.8 Process
      • 5.6.3.9 End User
      • 5.6.3.10 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Material Type
      • 5.6.4.8 Process
      • 5.6.4.9 End User
      • 5.6.4.10 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Material Type
      • 5.6.5.8 Process
      • 5.6.5.9 End User
      • 5.6.5.10 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Sartorius Stedim Biotech
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Eppendorf AG
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 GEA Group
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Pall Corporation
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Merck Millipore
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Thermo Fisher Scientific
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Watson-Marlow Fluid Technology Group
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Repligen Corporation
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Avantor Inc
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Corning Incorporated
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Sani-Tech West
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Sartorius AG
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 3M Company
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Danaher Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Applikon Biotechnology
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Meissner Filtration Products
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Parker Hannifin Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Saint-Gobain Life Sciences
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Cole-Parmer
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Getinge AB
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us